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Human papillomaviruses (HPV) remain a serious world
health problem due to their association with anogenital
and oral cancers and warts. While over 100 HPV types
have been identified, only a subset is associated with
malignancy. HPV16 and 18 are the most common onco-
genic types, while HPV6 and 11 are the most common
types responsible for anogenital warts. These four types
cause up to 90% of HPV-associated disease. While other
quantitative PCR (qPCR) assays can be used to detect
oncogenic HPV, there is no single tube assay that distin-
guishes the most frequent oncogenic types and the most
common types found in warts. A qPCR assay was devel-
oped that allowed for detection and quantitation of
these 4 HPV types. Type-specific primer pairs and Taq-
Man probes allowed single tube multiplex reactions to
be performed. Each HPV type was detected over a range
from 2 Η 10
1 to 2 Η 10
6 copies/reaction, providing a
reliable method of quantitating type-specific HPV.
A Sybr Green-based qPCR assay was developed that uti-
lizes degenerate primers targeting the E1 region of all
HPVs. These assays were run in parallel with PCR/
sequence gold standard on 76 oral cancers from HIV-
negative individuals. Cervical and oral washes were
collected from 25 HIV-positive women and 90 HIV-
positive men, respectively, being screened for anogenital
neoplasia. Samples were analyzed using the newly devel-
oped assays. Of the 115 samples, 16% were HPV posi-
tive. Cervical washes contained HPV types 44, 67, 35,
and 68 and oral specimens contained HPV types 16, 11,
32, 6, 55, 73, and 70. These results indicate that these
assays can be used to detect and quantitate HPV in clin-
ical samples obtained by noninvasive measures.
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